Kurz gefasst
Fachartikel in der Zeitschrift Applied Radiology, 2026-06. Verfasst von Janki Desai und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Spinal muscular atrophy (SMA) is an inherited neuromuscular disorder characterized by progressive muscle weakness. It has varying clinical severity, ranging from mild proximal muscle weakness to death from restrictive lung disease. The diagnosis is confirmed by genetic testing. Treatment includes survival motor neuron (SMN2) splicing modulator nusinersen, which may be challenging to administer intrathecally as patients develop varying degrees of scoliosis over time, making midline or paramedian lumbar punctures difficult. Patients with complex spinal anatomy may benefit from preprocedural and intraprocedural imaging to allow for a transforaminal approach for the intrathecal administration of nusinersen. Additional SMA treatments include risdiplam, a newer, oral splicing modulator, or SMN1 gene replacement therapy with Zolgensma.
Zitieren
APA
Desai, J., Towbin, R. B., Schaefer, C. M., & Towbin, A. J. (2026). Spinal Muscular Atrophy. Applied Radiology, 0(0), 1-5. https://doi.org/10.37549/jpcr-26-0082
Vancouver
Desai J, Towbin RB, Schaefer CM, Towbin AJ. Spinal Muscular Atrophy. Applied Radiology. 2026;0(0):1-5. doi:10.37549/jpcr-26-0082
BibTeX
@article{Desai2026,
author = {Desai, Janki and Towbin, Richard B. and Schaefer, Carrie M. and Towbin, Alexander J.},
title = {Spinal Muscular Atrophy},
journal = {Applied Radiology},
year = {2026},
volume = {0},
number = {0},
pages = {1--5},
doi = {10.37549/jpcr-26-0082}
}
EUVIMED